|
Fluorine in PDB 7rgz: Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-TalopyranosideProtein crystallography data
The structure of Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-Talopyranoside, PDB code: 7rgz
was solved by
P.M.Collins,
C.Kishor,
H.Blanchard,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 7rgz:
The structure of Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-Talopyranoside also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-Talopyranoside
(pdb code 7rgz). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-Talopyranoside, PDB code: 7rgz: Fluorine binding site 1 out of 1 in 7rgzGo back to![]() ![]()
Fluorine binding site 1 out
of 1 in the Crystal Structure of Human Galectin-3 Crd in Complex with Methyl 2-O- (2-Nitro-4-Fluoro)-Benzoyl-3-O-Toluoyl-B-D-Talopyranoside
![]() Mono view ![]() Stereo pair view
Reference:
K.Bum-Erdene,
P.M.Collins,
M.W.Hugo,
S.S.Tarighat,
F.Fei,
C.Kishor,
H.Leffler,
U.J.Nilsson,
J.Groffen,
I.D.Grice,
N.Heisterkamp,
H.Blanchard.
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia. J.Med.Chem. V. 65 5975 2022.
Page generated: Fri Aug 2 12:05:13 2024
ISSN: ISSN 0022-2623 PubMed: 35427125 DOI: 10.1021/ACS.JMEDCHEM.1C01296 |
Last articlesZn in 9MJ5Zn in 9HNW Zn in 9G0L Zn in 9FNE Zn in 9DZN Zn in 9E0I Zn in 9D32 Zn in 9DAK Zn in 8ZXC Zn in 8ZUF |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |